| Receipt no. | First name | Last name | Abstract title |
|---|
| 10105 | Ippei | Watanabe | Comparison of the Efficacy between First and Second Generation-Drug Eluting Stent for Coronary Bifurcation in Patients with Angina |
| 10358 | Masanobu | Ohya | Long-term (7-year) Clinical Outcomes after Biodegradable Polymer-based Biomatrix Biolimus-eluting Stent Implantation |
| 10557 | Hirofumi | Sugiyama | Long-Term Clinical Outcomes after Everolimus-Eluting Coronary Stent Implantation |
| 10739 | Masayuki | Mori | Early Endothelialization of Biolimus A9 with Bioresorbable Polymer Stent (Nobori®) in Porcine Coronary Model |
| 10794 | Yusuke | Adachi | Determinants of Left Ventricular Ejection Fraction Improvement following Coronary Artery Revascularization in Ischemic Heart Failure |
| 10795 | Takashi | Unoki | Vascular Endothelial Growth Factor Levels Associated with the Risk of Major Adverse Cardiac and Cerebrovascular Events After Drug-eluting Stent Implantation |
| 10831 | Naoki | Mori | Comparison of 2-year Clinical Outcomes between Long Single Stent and Overlapping Double Stent with Everolimus-Eluting Stents for Similar Long Lesions |
| 10856 | Yohsuke | Honda | Did all Bleeding events after DES implantation to be associated with poor prognosis? |
| 10881 | Takahiro | Tokuda | Long Term Clinical Outcomes after Second Generation DES Implantation in Real World. |
| 10921 | Daisuke | Ueshima | Effect of Over-2-Year Dual Antiplatelet Therapy on the Rate of Major Cardiac and Cerebral Adverse Events for Everolimus-Eluting Stent Implantation |
| 10925 | Daisuke | Ueshima | Treatment for Hyperlipidemia Can Reduce Both Major Adverse Cardiac and Cerebral Events and Major Bleeding in Triple antithrombotic therapy |
| 10940 | Masahiro | Toyama | Intra-Stent Thrombus Early After Stent Implantation is Associated With Cytochrome P450 2C19 Genotypes |
| 11126 | Hiromichi | Tamekiyo | Long-term Course of Angiographic Late Acquired Peri-stent Contrast Staining (LAPSS) after Sirolimus-Eluting Stent (SES) Implantation. |
| 11165 | Hiroto | Suzuyama | Impact of an excellent long term outcome after 2nd generation DES implantation for unprotected left main coronary artery bifurcation lesion |
| 11166 | Takeshi | Tada | Clinical Predictors of Progressive Peri-stent Contrast Staining |
| 11203 | Naofumi | Anjo | LDL/HDL ratio predicts the rate of uncovered stent strut evaluated by optical coherence tomography |
| 11249 | Shunji | Yoshikawa | Four-year Clinical Outcome of Everolimus-eluting Stent Implantation in Patients with Acute Coronary Syndrome: Investigation from Tokyo-MD PCI Multicenter Registry |
| 11254 | Goro | Yoshioka | "Full-metal jacket" stenting of drug eluting stent in 2-year follow-up |
| 11256 | Shunji | Yoshikawa | Serial Optical Coherence Tomography Assessment of Vascular Healing after Everolimus-eluting Stent Implantation in Acute Coronary Syndrome and Stable Angina Pectoris |
| 11294 | Yohei | Yakuta | The Initial and Late Followed Results of Drug-Eluting Stent for Small Target Vessels: Comparison between Xience, Promus and Resolute-Integrity Stent. |
| 11337 | Toru | Miyazaki | Four-Year Outcomes in Patients with Renal Dysfunction After Everolimus-eluting Stent Implantation: Results from Multicenter Tokyo-MD PCI Study |
| 11341 | Toru | Miyazaki | Impact of Renal Dysfunction on Clinical Outcomes with Everolimus-eluting Stents in Patients with Stable Angina: Results from Tokyo-MD PCI Study |
| 11344 | Tadateru | Takayama | Comparision of aspirin-rivaroxaban combination therapy versus dual antiplatelet therapy for coronary in-stent re-endothelialization and in swains with drug-eluting stent deployment |
| 11352 | Takashi | Hiromasa | Impact of Total Stent Length After Sirolimus-Eluting Stent Implantation on 7-Year Clinical Outcomes |
| 11357 | Naotaka | Akutsu | Comparison of neointimal feature between SYNERGY® and PROMUS® observed by serial angioscopy and optical coherence tomography –the SYNERGY® pilot study- |
| 11389 | Yuichirou | Sagawa | The predictors of in–stent restenosis after everolimus–eluting stent implantation in patients on hemodialysis |
| 11565 | Toru | Miyoshi | Neointimal quality, not quantity determines stent thrombogenecity after first and second generation drug-eluting stent implantation by chronic angioscopic study |
| 11587 | Yuzo | Kagawa | Angiographic and Clinical Outcomes of Second-Generation Drug-Eluting Stents in Patients on Hemodialysis |
| 11588 | Hiroshi | Takeshima | Impact of Chronic High-sensitive C-reactive Protein Levels on In-stent Restenosis in Patients Treated with XIENCE Stent |
| 11796 | Yohsuke | Honda | Predictors of bleeding events after DES implantation differ depending on the time period |
| 11833 | Noriaki | Tabata | Clinical Impact of Cancer on Adverse Cardiovascular Events after Percutaneous Coronary Intervention |
| 12214 | Katsuya | Miura | Ten-year Clinical Outcomes After The First Sirolimus-eluting Stent Implantation: Impact of In-stent Restenosis Lesion |
| 12243 | Hideki | Yano | Two (or four)-week interval optical coherence tomography: imaging evidence on neointimal coverage completion after implantation of the Xience Everolimus-eluting stent. |
| 12396 | Ryuta | Sugihara | Clinical Outcomes after Second Generation Drug-Eluting Stent Implantation at Right Coronary Artery Ostial Lesions, Compared with First Generation Drug-Eluting Stent. |
| 12688 | Yuzo | Kagawa | Long-term Angiographic Outcome of Sirolimus-eluting Stent and Everolimus-eluting Stent |
| 12744 | Hideki | Kitahara | Predictors of 5-Year Target Lesion Revascularization after Second Generation Drug-Eluting Stent Implantation: Intravascular Ultrasound and Angiographic Analyses |
| 12818 | Hideki | Kitahara | Stent Oversizing Improves Acute and Long-Term Outcomes after Drug-Eluting Stent Implantation in De Novo Coronary Lesions |
| 12861 | Takeshi | Ijichi | Comparisons of Vascular Reaction between Biodegradable Polymer Based Sirolimus and Permanent Polymer Based Everolimus Eluting Stents in Porcine Coronary Artery |
| 13212 | Yuji | Murakami | Platelet reactivity and clinical outcome after coronary drug-eluting stent implantation: a prospective single-center registry study |
| 13229 | Masashi | Yokoi | Long-term clinical results after first generation drug-eluting stent implantation |
| 13322 | Tatsuyuki | Sato | Impact of Prolonged Dual Antiplatelet Therapy on Ten-year Outcomes Following Drug-eluting Stent Implantation |
| 13349 | Maoto | Habara | Impact of Diabetes Mellitus for Angiographical Mid-term Outcome in New Generation Drug Eluting Stent |
| 13378 | Masashi | Yokoi | Impact of first generation drug-eluting stents on the long-term clinical results compared with bare-metal stent |
| 13391 | Yutaka | Goryo | Neointimal Condition after Second Generation Drug Eluting Stent Implantation is not Affected by Prolonged Dual Antiplatelet Therapy |
| 13409 | Yuhei | Yamaji | Impact of Renal Dysfunction on Very Long-Term(7 to 10 Years) Clinical Outcomes After Sirolimus-Eluting Stent Implantation. |
| 13456 | Makoto | Watanabe | Difference in Neointimal Proliferation after Thin- and Thick-Strut Drug Eluting Stents Implantation in Coronary Bifurcation Lesion: an OCT study |
| 13703 | Takenobu | Shimada | Predictors of Midterm Restenosis in Very Small Vessel Lesions After Treatment With 2.25 mm Drug-Eluting Stents |
| 13744 | Masakazu | Tsutsumi | Long-term Outcomes of First and Second Generation Drug-eluting Stent Implantation for Ostial Lesion of Left Main Coronary Artery. |
| 20078 | Kyung Hwan | Kim | Direct Comparison of Biodegradable Biolimus-eluting Stent Versus Durable Everolimus-eluting Stent: An Updated Meta-analysis |
